2.4 Specimen Collection, Handling, Storage, & Transport

CBIC Associate Infection Prevention and Control a-IPC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the CBIC a-IPC Certification 1.2 Exam Format, Scoring, & Logistics 1.3 Effective Study Strategies & Preparation Plan

2 Chapter 2: Processes to Identify Infectious Diseases

2.1 Chain of Infection & Pathogen Characteristics 2.2 Diagnostic & Laboratory Testing in IPC 2.3 Identifying Healthcare-Associated Infection Syndromes 2.4 Specimen Collection, Handling, Storage, & Transport 2.5 Colonization, Infection, Contamination, & Pseudo-Infection 2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use 2.7 Host Risk Factors & Emerging Infectious Disease Threats

3 Chapter 3: Surveillance and Epidemiologic Investigation

3.1 Surveillance Methods & Program Design 3.2 Epidemiological Calculations & Rate Metrics 3.3 Outbreak Investigation Protocols & Epidemic Curves 3.4 NHSN Definitions & Standardized Infection Ratios (SIR) 3.5 Descriptive Statistics & Presenting Surveillance Data 3.6 Surveillance Across the Care Continuum 3.7 Notifiable Disease Reporting, Data Sources, & Registries 3.8 Data Validation & Surveillance Program Evaluation 3.9 Outbreak Control Measures, Environmental Sampling, & Reporting

4 Chapter 4: Preventing and Controlling Transmission

4.1 Standard Precautions & Hand Hygiene Guidelines 4.2 Transmission-Based Precautions & Isolation Protocols 4.3 PPE Selection, Donning, Doffing, & Safety 4.4 Safe Injection Practices & Medication Preparation 4.5 Patient-Care Equipment & Point-of-Care Device Handling 4.6 Emergency Preparedness & the Infection Preventionist's Disaster Role 4.7 Bioterrorism, Special Pathogens, & Community Response Planning

5 Chapter 5: Environment of Care

5.1 Environmental Cleaning & Surface Disinfection 5.2 Water Utilities, Air Handling, & Building Systems 5.3 Construction, Renovation, & Infection Control Risk Assessment (ICRA) 5.4 Laundry, Linen, Waste Management, & Food Safety 5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

6 Chapter 6: Cleaning, Disinfection, and Sterilization of Medical Devices

6.1 Spaulding Classification System 6.2 Reprocessing Steps & High-Level Disinfection (HLD) 6.3 Sterilization Methods, Monitoring, & Quality Assurance 6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review 6.5 Reprocessing Failure Investigation & Patient Notification

7 Chapter 7: Employee and Occupational Health

7.1 Occupational Exposures & Post-Exposure Prophylaxis 7.2 Healthcare Personnel Immunizations & Screening 7.3 Work Restrictions & Fit-for-Duty Evaluations 7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

8 Chapter 8: Management, Communication, and Antimicrobial Stewardship

8.1 IPC Program Governance, Policies, & Accreditation 8.2 Interdisciplinary Collaboration & Crisis Communication 8.3 Antimicrobial Stewardship Principles & Interventions 8.4 Chain of Command, Resource Advocacy, & the Business Case

9 Chapter 9: Education, Research, and Performance Improvement

9.1 Adult Learning Principles & Staff Education 9.2 Quality Improvement Models & Implementation Science 9.3 Critical Appraisal of Infection Prevention Literature

2.4 Specimen Collection, Handling, Storage, & Transport

Key Takeaways Explain This Topic AI

Specimens should be collected before antimicrobial therapy begins whenever clinically feasible, because even one dose can suppress pathogen recovery and produce a falsely negative culture.

OSHA requires specimens of blood or other potentially infectious material to be placed in closed, leak-proof containers that are labeled with the biohazard symbol or color-coded red, with secondary containment if the primary container is contaminated.

Patient diagnostic specimens shipped off-site travel as UN 3373 Category B infectious substances under triple packaging; cultures of high-consequence pathogens travel as UN 2814 Category A.

Cerebrospinal fluid and anaerobic specimens must never be refrigerated because Neisseria meningitidis, Haemophilus influenzae, and obligate anaerobes die at cold temperatures.

A sputum specimen with more than 10 squamous epithelial cells per low-power field is oropharyngeal contamination and should be rejected rather than cultured.

Last updated: August 2026

2.4 Specimen Collection, Handling, Storage, & Transport

Quick Answer: Collect before antimicrobials , use aseptic technique , label at the bedside with two patient identifiers, place in a closed leak-proof container marked with the biohazard symbol or color-coded red (OSHA 29 CFR 1910.1030), transport promptly in the correct medium, and never refrigerate CSF or anaerobic specimens. Specimens shipped off-site move as UN 3373 Category B under triple packaging.

The infection preventionist rarely collects specimens personally, but the a-IPC blueprint asks candidates to identify appropriate practices for collection, handling, storage, and transportation. That is because pre-analytical error is the leading cause of misleading microbiology, and misleading microbiology corrupts everything downstream: unnecessary antibiotics, unnecessary isolation, false healthcare-associated infection (HAI) attribution, and distorted standardized infection ratios.

The Pre-Analytical Chain

Loading diagram...

1. Timing relative to antimicrobials

Collect before the first dose whenever the patient's condition allows. A single dose of a beta-lactam can sterilize a bloodstream within hours, converting a diagnosable bacteremia into a culture-negative sepsis syndrome that is then treated empirically and broadly for days. Where therapy has already started, note it on the requisition so the laboratory can use resin-containing or antimicrobial-neutralizing bottles.

2. Technique and volume

Blood cultures: disinfect skin with 2% chlorhexidine gluconate in 70% isopropyl alcohol and allow it to dry completely — contact time, not scrubbing, kills skin flora. Disinfect the bottle septum separately. Volume is the single strongest determinant of yield : 20–30 mL per set in adults, distributed across bottles. Draw two sets from two separate venipuncture sites, and avoid drawing through an existing catheter unless you are specifically evaluating a line infection with paired peripheral and central cultures.

Contamination benchmark: facilities should hold blood-culture contamination below 3.0% , with high performers under 1.0%. Rising contamination is an IPC and quality signal, not just a laboratory problem, because contaminated cultures drive vancomycin starts and false CLABSI investigations.

Wound specimens: aspirate purulent material or biopsy deep tissue. Superficial swabs of open ulcers grow colonizing flora and are of limited value; the same applies to swabbing sinus tracts.

Never culture: Foley catheter tips (they always grow biofilm organisms and do not diagnose urinary tract infection) or vent-circuit condensate.

3. Labeling and identification

Label at the bedside, at the time of collection , using two patient identifiers. Pre-labeling containers before entering the room and labeling in the hallway afterward are both mislabeling events waiting to happen; a mislabeled specimen can trigger isolation of the wrong patient and a false HAI.

Containment: What OSHA Actually Requires

Under the Bloodborne Pathogens Standard (29 CFR 1910.1030) , specimens of blood or other potentially infectious material must be placed in a container that:

• Prevents leakage during collection, handling, processing, storage, transport, and shipping;
• Is closed before being stored, transported, or shipped ;

Is labeled with the biohazard symbol or color-coded red . (Within a facility that uses Universal Precautions on all specimens, the labeling requirement may be relaxed only if containers are recognizable as specimens and stay inside the facility.)

Receives secondary containment — a second leak-proof container — if the outside of the primary container becomes contaminated or if puncture is a risk.

Specimens must never be transported in a gloved hand through a corridor, in a pocket, or in an open basin.

Shipping Classification for Infectious Substances

When specimens leave the facility — to a reference laboratory, a public health laboratory, or an outbreak investigation partner — Department of Transportation and IATA rules apply, and the classification depends on what the material can do.

Class UN number Applies to Packaging

Category A UN 2814 (affects humans) Cultures of high-consequence agents capable of causing permanent disability or life-threatening disease in otherwise healthy people (e.g., Ebola virus cultures, Bacillus anthracis cultures) Certified Packing Instruction 620; trained shipper required

Category B UN 3373 Routine patient diagnostic and clinical specimens — the overwhelming majority of what a hospital ships Triple packaging : leak-proof primary receptacle + absorbent + leak-proof secondary packaging + rigid outer with the UN 3373 diamond and "Biological Substance, Category B"

Exempt — Specimens with minimal likelihood of containing pathogens Basic leak-proof packaging

Exam Tip: Blueprint language calls this transportation of dangerous goods (TDG) . If a stem describes routine patient specimens going to a reference lab, the answer is Category B / UN 3373 triple packaging — not Category A, which is reserved for cultures and a short list of high-consequence agents.

Transport Media, Temperature, and Time

• Specimen Medium / container Temperature Time to lab
• Cerebrospinal fluid Sterile tube Room temperature — never refrigerate Immediately (<15 min)
• Blood cultures Aerobic + anaerobic bottles Room temperature or incubator <2 h; never refrigerate
• Urine Sterile cup or boric-acid tube Room temp ≤2 h, or refrigerate up to 24 h Refrigerate if delayed
• Stool for enteric pathogens Cary-Blair transport medium Room temperature in medium <2 h unpreserved
• Swabs (aerobic) Amies or Stuart transport medium Room temperature <2 h
• Anaerobic specimens Anaerobic transport vial/aspirate Room temperature — never refrigerate <2 h
• Viral specimens Viral transport medium Refrigerated (2–8°C) <72 h refrigerated

Refrigeration is not universally protective. It preserves urine bacterial counts, but it kills the fastidious organisms that matter most in meningitis and destroys obligate anaerobes.

Specimen Rejection Criteria

The laboratory should reject, and the IP should support rejection of:

• Unlabeled, mislabeled, or illegibly labeled specimens
• Leaking containers or specimens with contaminated exteriors

Specimens in the wrong medium — most commonly, tissue placed in formalin (which sterilizes it and destroys any chance of culture)

Specimens exceeding transport time or stored at the wrong temperature

Sputum with >10 squamous epithelial cells per low-power field (saliva, not lower respiratory secretions); a good specimen shows >25 polymorphonuclear cells and few squamous cells

• Duplicate specimens ordered within the same 24-hour window without clinical justification
• Formed stool submitted for Clostridioides difficile testing

Each rejection prevents a misleading result. When an IP sees the same rejection reason recurring on one unit, that is an education opportunity — a Domain 6 task that starts with a Domain 1 observation.